Global Regulatory Services (GRS) Launches New Support Ecosystem for Biologics Sector
Global Regulatory Services (GRS) launches a truly holistic service for the Biologics Sector providing a pathway from concept to the patient.
GRS has developed an ecosystem to fully support the evolution of Biologics to ensure that research will translate into commercial products to improve patient outcomes. We have gone beyond the conventional boundaries of regulatory affairs and quality compliance to be able to offer support, advice and guidance at the earliest stage possible. By getting involved at ‘grass roots’ level, we can help researchers define their vision and maximise their grant funding. GRS will also provide researchers with the opportunity to go beyond the end of the grant. We have the support and expertise needed to take these ‘concept’ biologics through to development and ultimately to the patient.
Bobby Deal, Managing Director: “I’m delighted to be able to offer this support to the Biological Sector because I strongly believe that there is a significant missing link between research and commercialisation. GRS is now that link and with the help of our great team of professionals we can maximise the opportunities for launching biological products into the clinic. As many already know, very few biologics make it beyond the end of the grant and we want to change that. I am convinced that these new therapies will be a huge benefit not only to patient welfare and quality of life but will also help to ease the financial pressures on our healthcare systems.”
Global Regulatory Services (GRS):
a global company offering a holistic approach to the regulatory requirements of the Life Science Industry. Headquartered in the UK with a global network of regulatory professionals and specialists GRS is able to support companies with emerging, novel technologies from foods to herbals, medical devices to IVDs, pharmaceuticals to regenerative therapies and borderline medicinal products. Specialist teams have been established who have both scientific and regulatory expertise with the ability to communicate effectively with the regulatory agencies. We continually fulfil our goal of “Driving Innovation to Market Success™”.
A Biological Product can be defined as:
an active substance produced or extracted from biological (living) system i.e. isolated from natural sources – human, animal or micro-organism. It consists of large complex molecules or a mixture of molecules. Examples of Biologics are: vaccines, blood or blood components, stem cells, tissues.
Greer Deal (Mrs), Director
Global Regulatory Services (GRS)
Global House, Painters Lane, Sutton, Ely, Cambridgeshire CB6 2NS, UK
Phone: +44 (0)1223 750638